CELTIC-19 – Ixaka’s targeted nanoparticle for CD19 haematological malignancies – has been granted Advanced Therapy Medicinal Product (ATMP) classification by the European Medicines Agency (EMA). The ...
WAKEFIELD, Mass.--(BUSINESS WIRE)--Myrtelle Inc., (“Myrtelle” or the “Company”), a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, ...
In one of the most diverse studies of the non-random medicinal plants selection by gender, age and exposure to outside influences from working with ecotourism projects, researchers worked with the ...